Kamyar Afarinkia

Kamyar Afarinkia is a Senior Lecturer at the University of West London's School of Human and Health Sciences, Department of Pharmacy and Biomolecular Sciences. His ORCID (0000-0003-2819-4364) confirms his active research profile with publications spanning 2022-2025.

Dr. Afarinkia's research focuses on:

• Cancer therapeutics targeting metabolic dysregulation in glioma
• Advanced drug delivery systems including niosomal formulations
• Development of novel antimicrobial agents against multidrug-resistant pathogens
• Application of NMR spectroscopy in pharmaceutical analysis
• Synthesis of innovative chemical compounds for therapeutic applications

His publication trend shows strong interdisciplinary work bridging oncology, medicinal chemistry, and pharmaceutical sciences. Recent work emphasizes repurposing existing drugs like metformin for cancer therapy while developing novel analytical methods and chemical entities. The consistent appearance as corresponding author across multiple high-impact journals (Translational Oncology, Cancers, RSC journals) demonstrates leadership in his research areas.

Dr. Afarinkia maintains active collaborations with researchers across international institutions, as evidenced by co-authorship with scholars from diverse geographical locations. His work demonstrates significant translational potential, connecting fundamental chemical research with clinical applications in cancer and infectious disease treatment.